REG-BARCLAYS PLC FORM 8.3 – WILLIS TOWERS WATSON PLC - AMENDMENT
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210721:nBw9kWXCda&default-theme=true
FORM 8.3 – WILLIS TOWERS WATSON PLC - AMENDMENT
Ap19 - Amendment to Purchase
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 19 July 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,893,213 1.47% 240,388 0.19%
(2) Derivatives (other than options):
72,359 0.06% 227,408 0.18%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
1,965,572 1.52% 467,796 0.36%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 4 215.7875 USD
Purchase 9 214.5300 USD
Purchase 9 219.2800 USD
Purchase 15 215.3200 USD
Purchase 15 216.7700 USD
Purchase 34 216.2500 USD
Purchase 34 216.2900 USD
Purchase 99 216.6260 USD
Purchase 175 217.7590 USD
Purchase 200 215.9100 USD
Purchase 315 216.7592 USD
Purchase 325 216.7884 USD
Purchase 600 216.8100 USD
Purchase 702 219.4132 USD
Purchase 1,147 216.6658 USD
Purchase 1,476 217.5584 USD
Purchase 1,763 215.2350 USD
Purchase 2,106 216.0994 USD
Purchase 2,269 216.0396 USD
Purchase 3,337 219.0073 USD
Purchase 3,695 216.0910 USD
Purchase 3,771 216.8865 USD
Purchase 5,538 216.8171 USD
Purchase 5,939 218.3055 USD
Purchase 6,015 216.3318 USD
Purchase 6,246 217.3463 USD
Purchase 6,730 217.3687 USD
Purchase 9,787 216.0900 USD
Purchase 11,252 215.9599 USD
Sale 1 214.6400 USD
Sale 1 216.0200 USD
Sale 1 220.0100 USD
Sale 1 215.9100 USD
Sale 2 216.4850 USD
Sale 6 215.2275 USD
Sale 35 215.4000 USD
Sale 50 214.9840 USD
Sale 100 220.2400 USD
Sale 191 220.1900 USD
Sale 225 219.8755 USD
Sale 453 216.2740 USD
Sale 511 219.1228 USD
Sale 875 217.1020 USD
Sale 885 215.7521 USD
Sale 1,347 216.5536 USD
Sale 1,384 216.2235 USD
Sale 1,690 216.1887 USD
Sale 2,055 217.0079 USD
Sale 2,106 216.0994 USD
Sale 2,880 216.2214 USD
Sale 9,588 216.0900 USD
Sale 10,075 216.5022 USD
Sale 13,043 215.8602 USD
Sale 25,000 217.7910 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Name Writing, Number Exercise Type Expiry Option
purchasing, of price date money
selling, securities paid/
varying etc to which received
option
relates
Call Option Selling 6,000 220 USD American 16 Jul 2021 2.8800 USD
Call Option Selling 100 240 USD American 16 Jul 2021 0.0500 USD
Put Option Selling 6,000 200 USD American 16 Jul 2021 0.3000 USD
Put Option Selling 100 220 USD American 16 Jul 2021 0.0100 USD
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 21 Jul 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210721005608/en/
(https://www.businesswire.com/news/home/20210721005608/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Barclays PLC - Director/PDMR Shareholding
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC Empiric Student Prop - Form 8.3 EMPIRIC STUDENT PROPERTY PLC
AnnouncementREG - Barclays PLC Unite Group PLC - Form 8.3 UNITE GROUP PLC, THE
Announcement